JAK2V617F mutation and hydroxyurea treatment as determinants of immature platelet parameters in essential thrombocythemia and polycythemia vera patients

Marina Panova-Noeva, Marina Marchetti, Sabrina Buoro, Laura Russo, Annamaria Leuzzi, Guido Finazzi, Alessandro Rambaldi, Cosimo Ottomano, Hugo ten Cate, Anna Falanga

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)2599-2601
JournalBlood
Volume118
Issue number9
DOIs
Publication statusPublished - 1 Sep 2011

Cite this

Panova-Noeva, M., Marchetti, M., Buoro, S., Russo, L., Leuzzi, A., Finazzi, G., Rambaldi, A., Ottomano, C., ten Cate, H., & Falanga, A. (2011). JAK2V617F mutation and hydroxyurea treatment as determinants of immature platelet parameters in essential thrombocythemia and polycythemia vera patients. Blood, 118(9), 2599-2601. https://doi.org/10.1182/blood-2011-02-339655